Collectively, these findings reveal a synergistic interaction between EGFR and Hh pathways, which converge to regulate SOX2 transcription, thereby jointly controlling the stem cell-like characteristics of SP cells in NSCLC (Figure 3). This evidence concerns the gene SOX2 and non-small cell lung carcinoma.